Monsanto Cutting 1,000 Jobs
by Claire Bernish (links at bottom)
St. Louis, MO — Agrichemical behemoth Monsanto plans to cut an additional 1,000 jobs to compensate, in part, for a slump in sales of its genetically-engineered corn seeds. The seeds led to a first quarter loss of $253 million — which, on the whole, represents a 17% drop in revenue.
“Monsanto has struggled in recent quarters to deal with slumping corn prices in the U.S., which have reduced demand for its best-selling product: genetically-enhanced [read: modified] corn seeds,” reported ABC News. “Farmers are shifting more acres to other crops after surpluses of corn and other crops, including wheat, have squashed commodity prices.”
In fact, Monsanto’s sales have fallen roughly 20% over the past year — perhaps indicative of the growing backlash against both its ubiquitous, genetically-modified crops, as well as the glyphosate-basedRoundup required to treat them. These financial hits mean the mega-corporation has been forced to restructure at a cost of between $1.1 billion and $1.2 billion — and together with the previously announced layoff of 2,600 people, Monsanto will now be trimming a full 16% of its total staff.
As Bloomberg reported: “Monsanto is facing the first drop in its annual earnings in six years as prices decline for its Roundup herbicide” and “lower crop prices curb farmers’ purchases of the newest genetically modified seeds.
“Monsanto’s sales of seeds and genetic licenses fell 14 percent in the first quarter. Revenue in the agricultural productivity unit, which primarily makes Roundup, tumbled 34 percent.”
Monsanto appears to be in a bit of trouble, despite its CEO, Hugh Grant’s claims that the restructuring has to do with meeting profit goals. European and North American farmers simply aren’t buying the chemically-dependent seeds, particularly since the World Health Organization categorized glyphosate as “probably carcinogenic” to humans — meaning it probably causes cancer.
In comparison to the same period last year, Monsanto’s revenue declined in every product category except GM soybeans.
Erin Elizabeth is a long time activist with a passion for the healing arts, working in that arena for a quarter century. Her site HealthNutNews.com is barely 4 years old, but cracked the top 20 Natural Health sites worldwide. She is an author, public speaker, and has recently done some TV and film programs for some of her original work which have attracted international media coverage. Erin was the recipient for the Doctors Who Rock "Truth in Journalism award for 2017. You can get Erin’s free e-book here and also watch a short documentary on how she overcame vaccine injuries, Lyme disease, significant weight gain, and more. Follow Erin on Facebook, Twitter, and Instagram.
P.S. You can subscribe to her Youtube Channel for breaking news, television appearances and more.
Latest posts by Erin Elizabeth (see all)
- Three different cannabinoid-based medicines approved by the FDA - January 18, 2018
- Get proper sleep nightly - January 18, 2018
- When it comes to almonds, what does ‘raw’ mean? You might be surprised - January 18, 2018
Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment.